$Sarepta疗法(SRPT)$ Announces FDA Approval of AMONDYS 45™ (casimersen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in Patients Amenable to Skipping Exon 45

iPhone转发:0回复:0喜欢:0